Search results
FTC votes 3-2 to ban non-compete clauses for American workers
United Press International via Yahoo Finance· 7 days ago"Noncompete clauses keep wages low, suppress new ideas and rob the American economy of dynamism,...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 1 hour ago“By filing bogus patent listings, pharma companies block competition and inflate the cost of...
The Biden Administration’s New Pro-Worker Rule Has Powerful Enemies
The New Republic via Yahoo Finance· 5 hours ago“Noncompete clauses keep wages low, suppress new ideas, and rob the American economy of dynamism,...
FTC chair Lina Khan’s ban of noncompete agreements is on firmer ground than her past overreach
Fortune via AOL· 6 days agoGood morning. The FTC took action to ban noncompete agreements yesterday, arguing they suppress...
U.S. bans noncompete agreements for nearly all jobs
NPR· 7 days agoThe FTC received more than 26,000 public comments in the months leading up to the vote. Chair Lina Khan referenced ...
FTC Bans Noncompete Clauses, Freeing Workers To Pursue New Jobs And Start Businesses
Forbes· 6 days ago“Noncompete clauses keep wages low, suppress new ideas and rob the American economy of dynamism,...
FTC bans noncompete clauses nationwide
NJBIZ· 6 days ago“Noncompete clauses keep wages low, suppress new ideas, and rob the American economy of dynamism, including from the more than 8,500 new startups that...
A Controversial Regulation: How the FTC Noncompete Ban Might Affect the Legal Industry | Law.com
Law.com· 15 hours agoThe Federal Trade Commission finalized a rule on April 23 banning noncompete agreements, and...
What is a noncompete agreement? Here's why the FTC banned them in the US
AZCentral | The Arizona Republic via Yahoo Finance· 6 days agoThe FTC said the ban would boost worker pay by up to $488 billion in the next decade and will lead to the creation of more than 8,500 new businesses each year, USA TODAY reported ...
FTC looking to accelerate inquiry into prescription-drug middlemen, chair says
Morningstar· 7 days agoThe Federal Trade Commission is working to accelerate its inquiry into the prescription-drug middlemen known as pharmacy-benefit managers, while also expanding its scrutiny of drug patents that ...